title: [The H63D mutation in the HFE gene is related to the risk of hepatocellular carcinoma].
abstract: OBJECTIVE
  To disclose whether mutations in the HFE gene inducing liver iron overload are related to the risk of hepatocellular carcinoma (HCC) in otherwise predisposed patients.
  
  
  METHODS
  One hundred and ninety-six patients (161 males) diagnosed with HCC and 181 healthy controls were included in the study. All subjects were white Spaniards.C282Y and H63D mutations in the HFE gene were identified in leucocyte genomic DNA using a polymerase chain reaction (PCR) and specific restriction enzymes. RESULTS (CASES/CONTROLS): 1. Genotype distribution: a) C282Y mutation: homozygotes 1/0, heterozygotes 12/23, wild type 183/158 (p = 0.07, non significant); b) H63D mutation: homozygotes 9/5, heterozygotes 85/52, wild type 102/124 (0dds ratio 2.00, 95% C.I. 1.29-3.12, p = 0.002. Four cases and 6 controls were carriers of heterozygous mixed genotypes. 2. Allele frequencies: a) C282Y mutation: wild type allele 378/339, mutated allele 14/23 (p = 0.11, non significant); b) H63D mutation: wild type allele 289/300, mutated allele 103/62 (0dds ratio 1.72, 95% C.I. 1.19-2.50, p = 0.004). Age at diagnosis, gender and etiology of the underlying liver disease do not influence these findings.
  
  
  CONCLUSIONS
  The C282Y mutation in the HFE gene is not related to the risk of HCC in non-hemochromatosis patients. The H63D mutation is associated with a higher risk of HCC in cirrhotic patients irrespective of their underlying liver disease.
authors.affiliation: Servicios de Hematología y Aparato Digestivo, Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Ropero
authors.forename: O
authors.initials: O
authors.lastname: Briceño
authors.forename: G
authors.initials: G
authors.lastname: López-Alonso
authors.forename: J A G
authors.initials: JA
authors.lastname: Agúndez
authors.forename: F A
authors.initials: FA
authors.lastname: González Fernández
authors.forename: F
authors.initials: F
authors.lastname: García-Hoz
authors.forename: A
authors.initials: A
authors.lastname: Villegas Martínez
authors.forename: M
authors.initials: M
authors.lastname: Díaz-Rubio
authors.forename: J M
authors.initials: JM
authors.lastname: Ladero
mesh_terms: D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000235:genetics*; D016022:Case-Control Studies; D005260:Female; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I / Q000235:genetics*; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics*; D008297:Male; D008565:Membrane Proteins / Q000235:genetics*; D009154:Mutation; D012307:Risk Factors
chemical_list: C103673:HFE protein, human; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I; D008565:Membrane Proteins